UBS Group
WGSWW

UBS Group’s GeneDx Holdings Warrant WGSWW Stock Holding History

UBS Group’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,344
Closed -$110 – 11233
2025
Q4 		$110 Buy
2,344
+1,967
+522% +$137 ﹤0.01% 10174
2025
Q3 		$41 Sell
377
-49,211
-99% -$4.07K ﹤0.01% 10047
2025
Q2 		$3.57K Sell
49,588
-93,663
-65% -$9.18K ﹤0.01% 9336
2025
Q1 		$30.1K Buy
143,251
+1,138
+0.8% +$255 ﹤0.01% 7942
2024
Q4 		$22.7K Sell
142,113
-1,292
-0.9% -$222 ﹤0.01% 7793
2024
Q3 		$10.8K Buy
143,405
+2,958
+2% +$102 ﹤0.01% 7712
2024
Q2 		$4.21K Buy
140,447
+4,774
+4% +$163 ﹤0.01% 8120
2024
Q1 		$7.46K Buy
135,673
+10,808
+9% +$425 ﹤0.01% 7384
2023
Q4 		$1.25K Buy
124,865
+21,097
+20% +$314 ﹤0.01% 8362
2023
Q3 		$3.11K Sell
103,768
-1,165
-1% -$32 ﹤0.01% 7608
2023
Q2 		$1.05K Sell
104,933
-3,856
-4% -$68 ﹤0.01% 8025
2023
Q1 		$1.96K Sell
108,789
-2,000
-2% -$48 ﹤0.01% 8618
2022
Q4 		$2.22K Buy
110,789
+44,419
+67% +$4.58K ﹤0.01% 9713
2022
Q3 		$15K Sell
66,370
-9,693
-13% -$2.72K ﹤0.01% 7831
2022
Q2 		$25K Buy
76,063
+74,627
+5,197% +$30.4K ﹤0.01% 6619
2022
Q1 		$1K Sell
1,436
-786
-35% -$544 ﹤0.01% 9941
2021
Q4 		$2K Sell
2,222
-8,998
-80% -$17.7K ﹤0.01% 9834
2021
Q3 		$24K Buy
11,220
+7,127
+174% +$23.4K ﹤0.01% 6985
2021
Q2 		$19K Buy
4,093
+3,735
+1,043% +$16K ﹤0.01% 7404
2021
Q1 		$2K Buy
358
+255
+248% +$1.42K ﹤0.01% 8650
2020
Q4 		$0 Buy
+103
New +$259 ﹤0.01% 8805

Other funds holding WGSWW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

UBS Group's WGSWW Position: Q1 2026 in Review

UBS Group sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2026, closing a stake of 2,344 shares — an estimated $110 sold.

UBS Group first reported a position in WGSWW in Q4 2020 and held it in 21 quarters. The position peaked at $30.1K in Q1 2025. 13 funds tracked by Wall St. Rank hold WGSWW as of Q1 2026.

  • UBS Group reported no remaining GeneDx Holdings Warrant position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 2,344 GeneDx Holdings Warrant shares in Q1 2026, an estimated $110.
  • UBS Group first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 21 quarters.
  • UBS Group's GeneDx Holdings Warrant position peaked at $30.1K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.